Cargando…

Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics

PURPOSE: We evaluated the relationship between the degree of osteopontin (OPN) expression in papillary thyroid carcinoma (PTC) specimens and the presence of the BRAF mutation and clinicopathologic variables. METHODS: Fifty-six snap-frozen thyroid tumor samples, including those of 49 PTCs, four folli...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kang, Kyung Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539115/ https://www.ncbi.nlm.nih.gov/pubmed/23323230 http://dx.doi.org/10.4174/jkss.2013.84.1.9

Ejemplares similares

The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid Carcinoma
por: Kong, Joon Seog, et al.
Publicado: (2018)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas
por: Schulten, Hans-Juergen, et al.
Publicado: (2015)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma
por: Henke, Lauren E, et al.
Publicado: (2015)

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates
por: Al-Salam, Suhail, et al.
Publicado: (2020)

Preliminary Study on the Relationship of BRAF Mutations with the Outcome of the First (131)I Radiotherapy and Malignant Biological Characteristics in Papillary Thyroid Carcinoma
por: Shangguan, Linjue, et al.
Publicado: (2021)

False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
por: Paek, Se Hyun, et al.
Publicado: (2017)

BRAF Testing in Multifocal Papillary Thyroid Carcinoma
por: Kimbrell, Hillary Z., et al.
Publicado: (2015)

The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors
por: Choi, Sun Yi, et al.
Publicado: (2013)

BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
por: Fakhruddin, Najla, et al.
Publicado: (2017)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)

Multicentric occurrence of multiple papillary thyroid carcinomas –HUMARA and BRAF mutation analysis
por: Nakazawa, Tadao, et al.
Publicado: (2015)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis
por: Li, Xin, et al.
Publicado: (2020)

SUN-LB78 Hyperfunctioning Papillary Thyroid Carcinoma With a BRAF Mutation
por: Shinkai, Shinsuke, et al.
Publicado: (2020)

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014)

Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients
por: Sun, Yun, et al.
Publicado: (2013)

Risk and Prognostic Factors for BRAF(V600E) Mutations in Papillary Thyroid Carcinoma
por: Wei, Xiaojing, et al.
Publicado: (2022)

The BRAF(V600E) mutation analysis and risk stratification in papillary thyroid carcinoma
por: Scheffel, Rafael Selbach, et al.
Publicado: (2020)

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
por: Yan, Changjiao, et al.
Publicado: (2019)

Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma
por: Li, Qian, et al.
Publicado: (2017)

Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma
por: Lim, Jinsun, et al.
Publicado: (2023)

Detection of Plasma BRAF(V600E) Mutation Is Associated with Lung Metastasis in Papillary Thyroid Carcinomas
por: Kim, Bo Hyun, et al.
Publicado: (2015)

Prevalence of BRAF(V600E) Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAF(V600E) Prevalent Area
por: Kim, Hyereen, et al.
Publicado: (2018)

High-density microarray expression profiling in conventional papillary thyroid carcinomas with versus without a BRAF mutation
por: Alotibi, Reem, et al.
Publicado: (2014)

Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics
por: Qi, Tingyue, et al.
Publicado: (2021)

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients
por: Yang, Li-Bo, et al.
Publicado: (2015)

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
por: Estrada-Flórez, Ana P, et al.
Publicado: (2019)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
por: Sun, Jian, et al.
Publicado: (2016)

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
por: Jin, Langping, et al.
Publicado: (2016)

Association analysis and the clinical significance of BRAF gene mutations and ultrasound features in papillary thyroid carcinoma
por: Liu, Ying, et al.
Publicado: (2019)

Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2020)

Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior
por: Ferreira, Luciana Bueno, et al.
Publicado: (2016)

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
por: Huang, Meiling, et al.
Publicado: (2019)

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
por: Kang, So Young, et al.
Publicado: (2013)

A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation
por: Pancer, Jill, et al.
Publicado: (2019)

Hashimoto’s Thyroiditis Minimizes Lymph Node Metastasis in BRAF Mutant Papillary Thyroid Carcinomas
por: Issa, Peter P., et al.
Publicado: (2022)

Correlation of Immunohistochemical Markers and BRAF Mutation Status with Histological Variants of Papillary Thyroid Carcinoma in the Korean Population
por: Min, Hye Sook, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rc4i8vaml4395r6mpa6rne40tj